SIR2: a potential target for calorie restriction mimetics

Trends in Molecular Medicine

Volumn 13, Issue 2, 2007, Pages 64-71

  Chen, Danica ^a   Guarente, Leonard ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN 2; SIRTUIN;

AGING; ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; CALORIC RESTRICTION; DEGENERATIVE DISEASE; DOWN REGULATION; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; HUNTINGTON CHOREA; LIFESPAN; METABOLIC REGULATION; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES CEREVISIAE;

AGING; ANIMALS; CAENORHABDITIS ELEGANS; CALORIC RESTRICTION; ENZYME INHIBITORS; HUMANS; LONGEVITY; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; NERVE DEGENERATION; SACCHAROMYCES CEREVISIAE; SIRTUINS; STILBENES;

CAENORHABDITIS ELEGANS; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 33846583673     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.12.004     Document Type: Review

References (69)

1. Koubova J., and Guarente L. How does calorie restriction work?. Genes Dev. 17 (2003) 313-321
2. Guarente L., and Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 408 (2000) 255-262
3. Rodgers J.T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434 (2005) 113-118
4. Bordone L., et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4 (2006) e31
5. Moynihan K.A., et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2 (2005) 105-117
6. Picard F., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429 (2004) 771-776
7. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004) 2011-2015
8. Cohen H.Y., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 (2004) 390-392
9. Luo J., et al. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107 (2001) 137-148
10. Motta M.C., et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 (2004) 551-563
11. Vaziri H., et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 (2001) 149-159
12. Wang C., et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 8 (2006) 1025-1031
13. Chen D., et al. Increase in activity during calorie restriction requires Sirt1. Science 310 (2005) 1641
14. Baur J.A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
15. Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell (2006) 10.1016/j.cell.2006.11.013
16. Fabrizio P., et al. Sir2 blocks extreme life-span extension. Cell 123 (2005) 655-667
17. Viswanathan M., et al. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell 9 (2005) 605-615
18. Chua K.F., et al. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab. 2 (2005) 67-76
19. Kaeberlein M., et al. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol. 2 (2004) E296
20. Lamming D.W., et al. HST2 mediates SIR2-independent life-span extension by calorie restriction. Science 309 (2005) 1861-1864
21. Lin S.J., and Guarente L. Increased life span due to calorie restriction in respiratory-deficient yeast. PLoS Genet 2 (2006) e33
22. Klar A.J.S., et al. MAR1 - a regulator of the HMa and HMα loci in Saccharomyces cerevisiae. Genetics 93 (1979) 37-50
23. Kennedy B.K., et al. Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell 80 (1995) 485-496
24. Kaeberlein M., et al. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13 (1999) 2570-2580
25. Sinclair D.A., and Guarente L. Extrachromosomal rDNA circles - a cause of aging in yeast. Cell 91 (1997) 1033-1042
26. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000) 793-798
27. Tissenbaum H.A., and Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410 (2001) 227-230
28. Rogina B., and Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15998-16003
29. Kenyon C. A conserved regulatory system for aging. Cell 105 (2001) 165-168
30. Berdichevsky A., et al. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125 (2006) 1165-1177
31. Imai S., et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000) 795-800
32. Lin S.J., et al. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289 (2000) 2126-2128
33. Anderson R.M., et al. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423 (2003) 181-185
34. Lin S.J., et al. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 18 (2004) 12-16
35. Kaeberlein M., et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310 (2005) 1193-1196
36. Wang Y., and Tissenbaum H.A. Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO. Mech. Ageing Dev. 127 (2006) 48-56
37. Howitz K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
38. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 10 (2003) 431-442
39. Langley E., et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21 (2002) 2383-2396
40. Ota H., et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 25 (2006) 176-185
41. Cheng H.L., et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10794-10799
42. McBurney M.W., et al. The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23 (2003) 38-54
43. Vega R.B., et al. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20 (2000) 1868-1876
44. Qin W., et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281 (2006) 21745-21754
45. Araki T., et al. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
46. Wang J., et al. A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell Biol. 170 (2005) 349-355
47. Chen J., et al. SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J. Biol. Chem. 280 (2005) 40364-40374
48. Yeung F., et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23 (2004) 2369-2380
49. Parker J.A., et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37 (2005) 349-350
50. Arumugam T.V., et al. Hormesis/preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev. 5 (2006) 165-178
51. Chen W.Y., et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123 (2005) 437-448
52. Yang Y., et al. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 24 (2005) 1021-1032
53. Bereshchenko O.R., et al. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32 (2002) 606-613
54. Heltweg B., et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 66 (2006) 4368-4377
55. Pruitt K., et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2 (2006) e40
56. Fu M., et al. The hormonal control of androgen receptor function through SIRT1. Mol. Cell. Biol. 26 (2006) 8122-8135
57. Michishita E., et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 16 (2005) 4623-4635
58. Onyango P., et al. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13653-13658
59. Schwer B., et al. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 158 (2002) 647-657
60. Shi T., et al. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280 (2005) 13560-13567
61. Hallows W.C., et al. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10230-10235
62. Schwer B., et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10224-10229
63. Haigis M.C., et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126 (2006) 941-954
64. Kim S.C., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23 (2006) 607-618
65. Kaeberlein M., et al. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280 (2005) 17038-17045
66. Wood J.G., et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430 (2004) 686-689
67. Valenzano D.R., et al. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16 (2006) 296-300
68. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
69. Zhang J. Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem. J. 397 (2006) 519-527